OPTICYTE

Founded in 2016, Opticyte was spun out of the University of Washington. Currently the medical device startup has secured more than $4.0M in non-dilutive funding from the National Institutes of Health through three SBIR/STTR grants, as well as angel investments. Opticyte employs engineering, regulatory, and communications teams with deep experience in bringing medical devices to market... The Opticyte Cell O₂ Monitor is the first device to measure oxygen levels inside cells in real-time.

Also known as: Opticyte, Inc.

Primary location: Seattle United States